Annemarie Moseley is COO & VP at BELLICUM PHARMACEUTICALS, INC (BLCM). They have made 5 open-market trades across 1 company since 2015, most recently 2016-12-01.
CIK 0001358403
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BLCM | 10,984 | $10K |
Shares reported on the most recent Form 4, priced at the 2016-12-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLCM | SELL | 2016-12-01 | 2016-12-05 | $17.54 | $877K | -13.7% | -19.6% | -33.3% |
| BLCM | SELL | 2016-12-01 | 2016-12-05 | $17.54 | $438K | -13.7% | -19.6% | -33.3% |
| BLCM | SELL | 2016-06-02 | 2016-06-06 | $13.00 | $325K | -5.5% | +4.4% | +32.4% |
| BLCM | SELL | 2016-01-04 | 2016-01-06 | $19.13 | $713K | -34.7% | -41.9% | -42.4% |
| BLCM | SELL | 2016-01-04 | 2016-01-06 | $19.01 | $622K | -34.7% | -41.9% | -42.4% |
| BLCM | SELL · 10b5-1 | 2015-07-01 | 2015-07-06 | $20.62 | $722K | -35.2% | -2.7% | -2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.